IBDEI10D ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,16401,1,4,0)
;;=4^N32.81
;;^UTILITY(U,$J,358.3,16401,2)
;;=^5015652
;;^UTILITY(U,$J,358.3,16402,0)
;;=Q61.2^^61^772^88
;;^UTILITY(U,$J,358.3,16402,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16402,1,3,0)
;;=3^Polycystic Kidney,Adult Type
;;^UTILITY(U,$J,358.3,16402,1,4,0)
;;=4^Q61.2
;;^UTILITY(U,$J,358.3,16402,2)
;;=^5018796
;;^UTILITY(U,$J,358.3,16403,0)
;;=N41.1^^61^772^92
;;^UTILITY(U,$J,358.3,16403,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16403,1,3,0)
;;=3^Prostatitis,Chronic
;;^UTILITY(U,$J,358.3,16403,1,4,0)
;;=4^N41.1
;;^UTILITY(U,$J,358.3,16403,2)
;;=^186931
;;^UTILITY(U,$J,358.3,16404,0)
;;=N11.9^^61^772^100
;;^UTILITY(U,$J,358.3,16404,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16404,1,3,0)
;;=3^Pyelonephritis,Chronic,Unspec
;;^UTILITY(U,$J,358.3,16404,1,4,0)
;;=4^N11.9
;;^UTILITY(U,$J,358.3,16404,2)
;;=^5015574
;;^UTILITY(U,$J,358.3,16405,0)
;;=N20.9^^61^772^118
;;^UTILITY(U,$J,358.3,16405,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16405,1,3,0)
;;=3^Urinary Calculus,Unspec
;;^UTILITY(U,$J,358.3,16405,1,4,0)
;;=4^N20.9
;;^UTILITY(U,$J,358.3,16405,2)
;;=^5015610
;;^UTILITY(U,$J,358.3,16406,0)
;;=R97.20^^61^772^31
;;^UTILITY(U,$J,358.3,16406,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16406,1,3,0)
;;=3^Elevated PSA
;;^UTILITY(U,$J,358.3,16406,1,4,0)
;;=4^R97.20
;;^UTILITY(U,$J,358.3,16406,2)
;;=^334262
;;^UTILITY(U,$J,358.3,16407,0)
;;=N52.36^^61^772^36
;;^UTILITY(U,$J,358.3,16407,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16407,1,3,0)
;;=3^Erectile Dysfunction After Interstitial Seed Therapy
;;^UTILITY(U,$J,358.3,16407,1,4,0)
;;=4^N52.36
;;^UTILITY(U,$J,358.3,16407,2)
;;=^5138933
;;^UTILITY(U,$J,358.3,16408,0)
;;=N52.37^^61^772^37
;;^UTILITY(U,$J,358.3,16408,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16408,1,3,0)
;;=3^Erectile Dysfunction After Prostate Ablative Therapy
;;^UTILITY(U,$J,358.3,16408,1,4,0)
;;=4^N52.37
;;^UTILITY(U,$J,358.3,16408,2)
;;=^5138934
;;^UTILITY(U,$J,358.3,16409,0)
;;=N52.35^^61^772^38
;;^UTILITY(U,$J,358.3,16409,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16409,1,3,0)
;;=3^Erectile Dysfunction After Radiation Therapy
;;^UTILITY(U,$J,358.3,16409,1,4,0)
;;=4^N52.35
;;^UTILITY(U,$J,358.3,16409,2)
;;=^5138932
;;^UTILITY(U,$J,358.3,16410,0)
;;=R31.21^^61^772^58
;;^UTILITY(U,$J,358.3,16410,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16410,1,3,0)
;;=3^Hematuria,Microscopic,Asymptomatic
;;^UTILITY(U,$J,358.3,16410,1,4,0)
;;=4^R31.21
;;^UTILITY(U,$J,358.3,16410,2)
;;=^5139198
;;^UTILITY(U,$J,358.3,16411,0)
;;=R31.29^^61^772^59
;;^UTILITY(U,$J,358.3,16411,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16411,1,3,0)
;;=3^Hematuria,Microscopic,Other
;;^UTILITY(U,$J,358.3,16411,1,4,0)
;;=4^R31.29
;;^UTILITY(U,$J,358.3,16411,2)
;;=^5019327
;;^UTILITY(U,$J,358.3,16412,0)
;;=R39.198^^61^772^72
;;^UTILITY(U,$J,358.3,16412,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16412,1,3,0)
;;=3^Micturition,Oth Difficulties
;;^UTILITY(U,$J,358.3,16412,1,4,0)
;;=4^R39.198
;;^UTILITY(U,$J,358.3,16412,2)
;;=^5019347
;;^UTILITY(U,$J,358.3,16413,0)
;;=R39.191^^61^772^74
;;^UTILITY(U,$J,358.3,16413,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,16413,1,3,0)
;;=3^Need to Immediately Re-Void
;;^UTILITY(U,$J,358.3,16413,1,4,0)
;;=4^R39.191
;;^UTILITY(U,$J,358.3,16413,2)
;;=^5139199
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI10D 3761 printed Apr 09, 2024@21:15:24 Page 2
IBDEI10D ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,16401,1,4,0)
+2 ;;=4^N32.81
+3 ;;^UTILITY(U,$J,358.3,16401,2)
+4 ;;=^5015652
+5 ;;^UTILITY(U,$J,358.3,16402,0)
+6 ;;=Q61.2^^61^772^88
+7 ;;^UTILITY(U,$J,358.3,16402,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,16402,1,3,0)
+10 ;;=3^Polycystic Kidney,Adult Type
+11 ;;^UTILITY(U,$J,358.3,16402,1,4,0)
+12 ;;=4^Q61.2
+13 ;;^UTILITY(U,$J,358.3,16402,2)
+14 ;;=^5018796
+15 ;;^UTILITY(U,$J,358.3,16403,0)
+16 ;;=N41.1^^61^772^92
+17 ;;^UTILITY(U,$J,358.3,16403,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,16403,1,3,0)
+20 ;;=3^Prostatitis,Chronic
+21 ;;^UTILITY(U,$J,358.3,16403,1,4,0)
+22 ;;=4^N41.1
+23 ;;^UTILITY(U,$J,358.3,16403,2)
+24 ;;=^186931
+25 ;;^UTILITY(U,$J,358.3,16404,0)
+26 ;;=N11.9^^61^772^100
+27 ;;^UTILITY(U,$J,358.3,16404,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,16404,1,3,0)
+30 ;;=3^Pyelonephritis,Chronic,Unspec
+31 ;;^UTILITY(U,$J,358.3,16404,1,4,0)
+32 ;;=4^N11.9
+33 ;;^UTILITY(U,$J,358.3,16404,2)
+34 ;;=^5015574
+35 ;;^UTILITY(U,$J,358.3,16405,0)
+36 ;;=N20.9^^61^772^118
+37 ;;^UTILITY(U,$J,358.3,16405,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,16405,1,3,0)
+40 ;;=3^Urinary Calculus,Unspec
+41 ;;^UTILITY(U,$J,358.3,16405,1,4,0)
+42 ;;=4^N20.9
+43 ;;^UTILITY(U,$J,358.3,16405,2)
+44 ;;=^5015610
+45 ;;^UTILITY(U,$J,358.3,16406,0)
+46 ;;=R97.20^^61^772^31
+47 ;;^UTILITY(U,$J,358.3,16406,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,16406,1,3,0)
+50 ;;=3^Elevated PSA
+51 ;;^UTILITY(U,$J,358.3,16406,1,4,0)
+52 ;;=4^R97.20
+53 ;;^UTILITY(U,$J,358.3,16406,2)
+54 ;;=^334262
+55 ;;^UTILITY(U,$J,358.3,16407,0)
+56 ;;=N52.36^^61^772^36
+57 ;;^UTILITY(U,$J,358.3,16407,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,16407,1,3,0)
+60 ;;=3^Erectile Dysfunction After Interstitial Seed Therapy
+61 ;;^UTILITY(U,$J,358.3,16407,1,4,0)
+62 ;;=4^N52.36
+63 ;;^UTILITY(U,$J,358.3,16407,2)
+64 ;;=^5138933
+65 ;;^UTILITY(U,$J,358.3,16408,0)
+66 ;;=N52.37^^61^772^37
+67 ;;^UTILITY(U,$J,358.3,16408,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,16408,1,3,0)
+70 ;;=3^Erectile Dysfunction After Prostate Ablative Therapy
+71 ;;^UTILITY(U,$J,358.3,16408,1,4,0)
+72 ;;=4^N52.37
+73 ;;^UTILITY(U,$J,358.3,16408,2)
+74 ;;=^5138934
+75 ;;^UTILITY(U,$J,358.3,16409,0)
+76 ;;=N52.35^^61^772^38
+77 ;;^UTILITY(U,$J,358.3,16409,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,16409,1,3,0)
+80 ;;=3^Erectile Dysfunction After Radiation Therapy
+81 ;;^UTILITY(U,$J,358.3,16409,1,4,0)
+82 ;;=4^N52.35
+83 ;;^UTILITY(U,$J,358.3,16409,2)
+84 ;;=^5138932
+85 ;;^UTILITY(U,$J,358.3,16410,0)
+86 ;;=R31.21^^61^772^58
+87 ;;^UTILITY(U,$J,358.3,16410,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,16410,1,3,0)
+90 ;;=3^Hematuria,Microscopic,Asymptomatic
+91 ;;^UTILITY(U,$J,358.3,16410,1,4,0)
+92 ;;=4^R31.21
+93 ;;^UTILITY(U,$J,358.3,16410,2)
+94 ;;=^5139198
+95 ;;^UTILITY(U,$J,358.3,16411,0)
+96 ;;=R31.29^^61^772^59
+97 ;;^UTILITY(U,$J,358.3,16411,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,16411,1,3,0)
+100 ;;=3^Hematuria,Microscopic,Other
+101 ;;^UTILITY(U,$J,358.3,16411,1,4,0)
+102 ;;=4^R31.29
+103 ;;^UTILITY(U,$J,358.3,16411,2)
+104 ;;=^5019327
+105 ;;^UTILITY(U,$J,358.3,16412,0)
+106 ;;=R39.198^^61^772^72
+107 ;;^UTILITY(U,$J,358.3,16412,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,16412,1,3,0)
+110 ;;=3^Micturition,Oth Difficulties
+111 ;;^UTILITY(U,$J,358.3,16412,1,4,0)
+112 ;;=4^R39.198
+113 ;;^UTILITY(U,$J,358.3,16412,2)
+114 ;;=^5019347
+115 ;;^UTILITY(U,$J,358.3,16413,0)
+116 ;;=R39.191^^61^772^74
+117 ;;^UTILITY(U,$J,358.3,16413,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,16413,1,3,0)
+120 ;;=3^Need to Immediately Re-Void
+121 ;;^UTILITY(U,$J,358.3,16413,1,4,0)
+122 ;;=4^R39.191
+123 ;;^UTILITY(U,$J,358.3,16413,2)
+124 ;;=^5139199
